MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective and neuromodulatory properties of Olea purpurea leaf extract in MPTP intoxicated Parkinsonian rat model

A. Singh, T. Yadav, A. Pandey (Allahabad, India)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1064

Keywords: Behavioral abnormalities, Oxidative stress, Parkinsonism

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: This study aimed to isolate and characterize Olea purpurea leaf extract, and its neuroprotective effect in MPTP induced parkinsonian rat model.

Background: Parkinson’s disease (PD), also known as shaking palsy, is a progressive neurodegenerative disorder that encompasses both motor- and non-motor dysfunctions, with deteriorating effects on mobility and muscle control. Several recent studies have reported the involvement of oxidative stress in neurodegeneration and neuro-inflammation

Method: Olea purpurea leaves were taken, and shade dried. Extract (OPE) was prepared in the soxhlet with the polarity of the solvent. In-vitro antioxidant and total phenol and flavonoid content were assessed. Methanolic leaf extract was found to have maximum antioxidant activity and chosen for further in vivo studies. The extract HPLC analysis showed the presence of flavonoid tyrosol in higher concentrations. A total of 21 rats was taken and divided into three groups. Control, given intraperitoneal injection (i.p) of saline, MPTP intoxicated, given i.p two doses of MPTP (30 mg/kg body weight) at 16 h interval, OPE treated rats, MPTP+OPE (100 mg/kg body weight) orally for 28 days. Bodyweight, locomotor behavior monitored weekly. At the end of the experiment, brains were collected for performing biochemical assays, gene expression, and immunohistochemical analysis.

Results: After seven days of treatment rotarod timing, hanging test was found to decrease, and narrow beam timing increased in MPTP administered rats compared to normal rats. OPE administration improves the timing at normalcy. Brain tissue of MPTP rats shows up-regulated level of lipid peroxidation, nitrite level, protein carbonyl, and down-regulated level of SOD, catalase, and GSH. Restorative effects seen in OPE fed rats. mRNA level analysis showed the elevated level of IL-1β, TNF-α, and downregulation of the Il-10 level in MPTP treated rats while OPE treated rats significantly restored their level. It is apparent from the immunohistochemical study that OPE treatment inhibits the MPTP induced activation of NF-κB.

Conclusion: Our experimental finding suggest that olea purpurea leaf extract showed neuromodulation and neuroprotective potential against MPTP induced nigrostriatal dopaminergic, and also exhibits anti-inflammatory activity.

To cite this abstract in AMA style:

A. Singh, T. Yadav, A. Pandey. Neuroprotective and neuromodulatory properties of Olea purpurea leaf extract in MPTP intoxicated Parkinsonian rat model [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/neuroprotective-and-neuromodulatory-properties-of-olea-purpurea-leaf-extract-in-mptp-intoxicated-parkinsonian-rat-model/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-and-neuromodulatory-properties-of-olea-purpurea-leaf-extract-in-mptp-intoxicated-parkinsonian-rat-model/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley